| 1DTQ | A:91-115,A:157-225; A:226-319; A:320-426; B:237-341; B:342-426; B:91-115,B:157-236 | CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH PETT-1 (PETT131A94) |
| 1DTT | B:94-115,B:157-237; A:226-319; A:320-426; B:322-432; B:238-321; A:91-115,A:157-225 | CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH PETT-2 (PETT130A94) |
| 1HAR | A:104-115,A:160-216 | 2.2 ANGSTROMS RESOLUTION STRUCTURE OF THE AMINO-TERMINAL HALF OF HIV-1 REVERSE TRANSCRIPTASE (FINGERS AND PALM SUBDOMAINS) |
| 1HNV | B:95-115,B:157-235; A:91-115,A:157-225; A:226-319; B:236-319; A:320-426; B:320-426 | STRUCTURE OF HIV-1 RT(SLASH)TIBO R 86183 COMPLEX REVEALS SIMILARITY IN THE BINDING OF DIVERSE NONNUCLEOSIDE INHIBITORS |
| 1HPZ | B:99-115,B:157-238; A:91-115,A:157-225; A:226-319; B:239-319; A:320-426; B:320-426 | HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
| 1HQE | B:99-115,B:157-238; A:91-115,A:157-225; A:226-319; B:239-319; A:320-426; B:320-426 | HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
| 1HQU | B:95-115,B:157-234; A:91-115,A:157-225; A:226-319; B:235-319; A:320-426; B:320-426 | HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 |
| 2WOM | B:95-115,B:157-233; A:91-115,A:157-225; A:226-319; B:234-319; A:320-426; B:320-426 | CRYSTAL STRUCTURE OF UK-453061 BOUND TO HIV-1 REVERSE TRANSCRIPTASE (K103N). |
| 2WON | A:91-115,A:157-225; A:226-319; A:320-426; B:237-341; B:342-426; B:93-115,B:157-236 | CRYSTAL STRUCTURE OF UK-453061 BOUND TO HIV-1 REVERSE TRANSCRIPTASE (WILD-TYPE). |
)
)